SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 26, 16:01
320.35
0.05 (0.02%)
VOLUME 41,634
LIVE
NSE
May 26, 16:01
320.15
0.55 (0.17%)
VOLUME 511,318
News on Cadila Healthcare
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Nifty on a high: experts bet on bank, auto to lead rally 

2.36 pm | 26 May 2016 |  Source: CNBC-TV18

Nifty may see some fleeting short-term resistance, but there are no major hurdles going forward and it may touch 8700 levels soon, says Jai Bala of Ca...

Zydus Cadila gets USFDA's final nod for fungal treatment drug

1.04 pm | 25 May 2016 |  Source: PTI

The Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Voriconazole tablets in strengths of 50 and 20...

Zydus receives final approval from USFDA for Voriconazole tablets

12.07 pm | 25 May 2016 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Voriconazole tablets in strengths of 50 mg and 200 mg. ...

Bullish on JSW Energy; Infy may outdo peers soon: Equirus Sec 

12.47 pm | 18 May 2016 |  Source: CNBC-TV18

Panjak Sharma of Equirus Securities is bullish on JSW Energy, Ashoka Buildcon, Infosys and Exide Industries, while not so positive on Cadila Healthcar...

Buy Cadila Health 320 Put, RIL 980 Call: Rahul Shah 

2.37 pm | 16 May 2016 |  Source: CNBC-TV18

Rahul Shah of Motilal Oswal is of the view that one can buy Cadila Healthcare 320 Put and Reliance Industries 980 Call....

Cadila Healthcare Q4 net up 11% at Rs 389 cr

3.36 pm | 13 May 2016 |  Source: PTI

The company had posted a net profit after taxes, minority interest and share of profit of associates of Rs 350.4 crore in the corresponding period of ...

Cadila Health Q4 net may rise 7%, R&D likely to hurt margins

9.30 am | 13 May 2016 |  Source: Moneycontrol.com

During the quarter, EBITDA may increase 11 percent to Rs 551 crore compared to Rs 496 crore while operating profit margin may stand at 22 percent from...

Morning Cues: Nifty may open in red on weak Asian cues

7.56 am | 13 May 2016 |  Source: Moneycontrol.com

Markets in Asia opened lower in early trade, following a modest finish in US equities. In addition, Bank of Korea is expected to announce its monetary...

Zydus Cadila gets USFDA nod to sell generic diabetes drug

1.58 pm | 11 May 2016 |  Source: PTI

The group has received final approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 1.25, 2.5 and 5 mg, Zydus Ca...

Zydus receives final approval from USFDA for Glyburide tablets

1.26 pm | 11 May 2016 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Glyburide tablets USP in strengths of 1.25, 2.5 and 5mg....

Here is why SP Tulsian is bullish on Ujjivan Financial 

6.47 pm | 10 May 2016 |  Source: CNBC-TV18

In an interview with CNBC-TV18, SP Tulsian, sptulsian.com, shares his views on the microfinance space and sugar stocks....

Buy Cadila Health, Tata Chemicals, Prakash Ind: Gujral 

1.59 pm | 10 May 2016 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying Cadila Healthcare, Tata Chemicals and Prakash Industries....

Buy Maruti Suzuki on all declines: Ashwani Gujral 

1.59 pm | 10 May 2016 |  Source: NEWS18.com

Ashwani Gujral of ashwanigujral.com is of the view that one can buy Maruti Suzuki on all declines....

Cadila Healthcare's FY16 results on May 13, 2016

10.56 am | 25 Apr 2016 |  Source: Moneycontrol.com

Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2016, to consider & approve the...

Sell Arvind, Cadila Healthcare: Sudarshan Sukhani 

10.46 am | 18 Apr 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends selling Arvind and Cadila Healthcare....

Cadila Healthcare Q3 profit jumps 38%, EBITDA beats estimates 

12.09 pm | 05 Feb 2016 |  Source: Moneycontrol.com

Operating profit (earnings before interest, tax, depreciation and amortisation) grew by 29.5 percent year-on-year to Rs 578.7 crore and margin has see...

Cadila Health Q3 profit may surge 33% to Rs 376 cr: Poll

4.33 pm | 04 Feb 2016 |  Source: CNBC-TV18

Revenue growth is likely to be led by 12-14 percent Y-o-Y growth in US formulations while sequential US growth may remain flat due to no US launch dur...

Buy Cadila Healthcare; target of Rs 356: KRChoksey

6.37 pm | 12 Jan 2016 |  Source: Moneycontrol.com

KRChoksey is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target price of Rs 365 in its research report dated Janua...

1 2 3 4
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.